- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/14 - VasoprotectivesAntihaemorrhoidalsDrugs for varicose therapyCapillary stabilisers
Patent holdings for IPC class A61P 9/14
Total number of patents in this class: 635
10-year publication summary
|
16
|
16
|
34
|
46
|
56
|
53
|
62
|
54
|
50
|
21
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Osaka University | 3377 |
8 |
| Daiichi Sankyo Company, Limited | 1874 |
7 |
| Kowa Company, Ltd. | 1196 |
7 |
| The Johns Hopkins University | 5671 |
6 |
| National University Corporation Hamamatsu University School of Medicine | 116 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4261 |
6 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
5 |
| Kinki University | 244 |
5 |
| Mercator Medsystems, Inc. | 49 |
5 |
| The Regents of the University of California | 19943 |
4 |
| Boehringer Ingelheim International GmbH | 4644 |
4 |
| Lunamed AG | 13 |
4 |
| Morinaga Milk Industry Co., Ltd. | 357 |
4 |
| The University of Tokyo | 4182 |
4 |
| Sanofi | 4068 |
4 |
| Novartis AG | 10829 |
3 |
| Centre National de La Recherche Scientifique | 10442 |
3 |
| The Trustees of Columbia University in the City of New York | 3577 |
3 |
| Amarin Pharmaceuticals Ireland Limited | 270 |
3 |
| Astellas Pharma Inc. | 1091 |
3 |
| Other owners | 541 |